Abstract:Despite significant advances in cancer therapy, there is an urgent need for drugs with a new mode of action that will preferentially kill cancer cells. Several cationic antimicrobial peptides, which bind strongly to negatively charged membranes, were shown to kill cancer cells slightly better than normal cells. This was explained by a slight increase (3-9%) in the level of the negatively charged membrane phosphatidylserine (PS) in many cancer cells compared to their normal counterparts. Unfortunately, however, these peptides are inactivated by serum components. Here we synthesized and investigated the anticancer activity and the role of peptide charge, peptide structure, and phospholipid headgroup charge on the activity of a new group of diastereomeric lytic peptides (containing D- and L-forms of leucine and lysine; 15-17 amino acids long). The peptides are highly toxic to cancer cells, to a degree similar to or larger than that of mitomycin C. However, compared with mitomycin C and many native antimicrobial peptides, they are more selective for cancer cells. The peptides were investigated for (i) their binding to mono- and bilayer membranes by using the surface plasmon resonance (SPR) technique, (ii) their ability to permeate membranes by using fluorescence spectroscopy, (iii) their structure and their effect on the lipid order by using ATR-FTIR spectroscopy, and (iv) their ability to bind to cancer versus normal cells by using confocal microscopy. The data suggest that the peptides disintegrate the cell membrane in a detergent-like manner. However, in contrast to native antimicrobial peptides, the diastereomers bind and permeate similarly zwitterionic and PS-containing model membranes. Therefore, cell selectivity is probably determined mainly by improved electrostatic attraction of the peptides to acidic components on the surface of cancer cells (e.g., O-glycosylation of mucines). The simple composition of the diastereomeric peptides and their stability regarding enzymatic degradation by serum components make them excellent candidates for new chemotherapeutic drugs.

Targeting Cell Membrane by Charge-Reversal Amphiphilic Pillar[5]arene for the Selective Killing of Cancer Cells.

Ph-Induced Charge-Reversal Amphiphile with Cancer Cell-Selective Membrane-Disrupting Activity.

Controllable Construction of Biocompatible Supramolecular Micelles and Vesicles by Water-Soluble Phosphate Pillar[5,6]arenes for Selective Anti-Cancer Drug Delivery

Fabrication of a Targeted Drug Delivery System from a Pillar[5]arene‐Based Supramolecular Diblock Copolymeric Amphiphile for Effective Cancer Therapy

Cationic Pillar[6]arene Induces Cell Apoptosis by Inhibiting Protein Tyrosine Phosphorylation Via Host–Guest Recognition

Polydopamine Modified by Pillar[5]arene in Situ for Targeted Chemo-Photothermal Cancer Therapy.

Cationic Pillar[6]Arene/Atp Host-Guest Recognition: Selectivity, Inhibition of Atp Hydrolysis, and Application in Multidrug Resistance Treatment

Selective Killing of Cancer Cells by Nonplanar Aromatic Hydrocarbon-Induced DNA Damage.

Supramolecular chemotherapeutic drug constructed from pillararene-based supramolecular amphiphile.

A Charge Reversible Self‐Delivery Chimeric Peptide with Cell Membrane‐Targeting Properties for Enhanced Photodynamic Therapy

Charge-reversal polyamidoamine dendrimer for cascade nuclear drug delivery.

Intelligent Supramolecular Polypeptide Prodrug Based on Pillar[5]Arene Host-Guest Recognition for Enhanced Cancer Therapy

New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cells

Charge-reversible crosslinked nanoparticle for pro-apoptotic peptide delivery and synergistic photodynamic cancer therapy

Lysosome‐Targeted and Fluorescence‐Turned “On” Cytotoxicity Induced by Alkaline Phosphatase‐Triggered Self‐Assembly

Dual pH and Ca2+‐Responsive PEG‐Modified Pillar[5]arene‐Based Supramolecular Nanodrug Delivery System: Excellent Cargo Encapsulation and Minimal Drug Toxicity

Charge‐Reversal Drug Conjugate for Targeted Cancer Cell Nuclear Drug Delivery

Pillar[6]arene-Based Supramolecular Nanocatalysts for Synergistically Enhanced Chemodynamic Therapy by the Intracellular Cascade Reaction

Disruption of Tumor Cells Using a Ph-Activated and Thermosensitive Antitumor Lipopeptide Containing a Leucine Zipper Structure

A Pillar[5]arene-Based [2]rotaxane Lights Up Mitochondria.

Dual-Responsive Polymer Micelles for Target-Cell-Specific Anticancer Drug Delivery